PL3129057T3 - Glikolipidy i ich kompozycje farmaceutyczne do stosowania w leczeniu - Google Patents
Glikolipidy i ich kompozycje farmaceutyczne do stosowania w leczeniuInfo
- Publication number
- PL3129057T3 PL3129057T3 PL15717051.5T PL15717051T PL3129057T3 PL 3129057 T3 PL3129057 T3 PL 3129057T3 PL 15717051 T PL15717051 T PL 15717051T PL 3129057 T3 PL3129057 T3 PL 3129057T3
- Authority
- PL
- Poland
- Prior art keywords
- glycolipids
- therapy
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 229930186217 Glycolipid Natural products 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1406172.5A GB201406172D0 (en) | 2014-04-04 | 2014-04-04 | Therapy and pharmaceutical composition |
| PCT/GB2015/051068 WO2015150839A1 (en) | 2014-04-04 | 2015-04-07 | Glycolipids and pharmaceutical compositions thereof for use in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3129057T3 true PL3129057T3 (pl) | 2023-12-18 |
Family
ID=50776888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15717051.5T PL3129057T3 (pl) | 2014-04-04 | 2015-04-07 | Glikolipidy i ich kompozycje farmaceutyczne do stosowania w leczeniu |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10428102B2 (pl) |
| EP (2) | EP3129057B1 (pl) |
| CN (2) | CN114685414A (pl) |
| AU (3) | AU2015242363C1 (pl) |
| CA (2) | CA3209430A1 (pl) |
| DK (1) | DK3129057T3 (pl) |
| ES (1) | ES2958492T3 (pl) |
| GB (1) | GB201406172D0 (pl) |
| MX (2) | MX392452B (pl) |
| PL (1) | PL3129057T3 (pl) |
| WO (1) | WO2015150839A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201406172D0 (en) | 2014-04-04 | 2014-05-21 | Univ Nottingham | Therapy and pharmaceutical composition |
| EP3658152A1 (en) * | 2017-07-28 | 2020-06-03 | The University Of Nottingham | Fruit extract and uses thereof |
| WO2019147300A1 (en) * | 2018-01-23 | 2019-08-01 | Academia Sinica | Use of crassocephalum rabens extract in the treatment of breast cancer |
| GB201903873D0 (en) * | 2019-03-21 | 2019-05-08 | Univ Nottingham | Enhanced transfection |
| GB202203181D0 (en) * | 2022-03-08 | 2022-04-20 | Aceae Nutra Ltd | Inhibitors of elF4A |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2668930B1 (fr) * | 1990-11-09 | 1995-02-17 | Oreal | Composition cosmetique, pharmaceutique ou alimentaire comportant une dispersion aqueuse de vesicules lipidiques. |
| GB9819384D0 (en) * | 1998-09-04 | 1998-10-28 | Cerebrus Ltd | Chemical compounds II |
| JP2006117582A (ja) | 2004-10-21 | 2006-05-11 | Fancl Corp | インターロイキン４産生抑制剤とその利用 |
| PT1831159E (pt) * | 2004-12-21 | 2010-03-03 | Hoffmann La Roche | Derivados de tetralina e de indano e as suas utilizações |
| PE20070523A1 (es) * | 2005-09-12 | 2007-06-28 | Wyeth Corp | Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona |
| US7547455B2 (en) * | 2006-09-20 | 2009-06-16 | Academia Sinica | Cancer and inflammatory disorder treatment |
| WO2010048955A1 (en) * | 2008-10-30 | 2010-05-06 | Hyben Vital Licens Aps | Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition |
| WO2013152299A2 (en) | 2012-04-06 | 2013-10-10 | University Of North Carolina At Chapel Hill | Inhibitors of eif4a and derivatives of pateamine a with antiviral activity and use |
| GB201406172D0 (en) | 2014-04-04 | 2014-05-21 | Univ Nottingham | Therapy and pharmaceutical composition |
| US9649078B2 (en) | 2015-07-28 | 2017-05-16 | Dental Imaging Technologies Corporation | Hybrid X-ray system with detachable radiation shield |
-
2014
- 2014-04-04 GB GBGB1406172.5A patent/GB201406172D0/en not_active Ceased
-
2015
- 2015-04-07 CN CN202210339323.8A patent/CN114685414A/zh active Pending
- 2015-04-07 EP EP15717051.5A patent/EP3129057B1/en active Active
- 2015-04-07 CN CN201580030017.4A patent/CN106413753B/zh active Active
- 2015-04-07 WO PCT/GB2015/051068 patent/WO2015150839A1/en not_active Ceased
- 2015-04-07 US US15/301,264 patent/US10428102B2/en active Active
- 2015-04-07 AU AU2015242363A patent/AU2015242363C1/en active Active
- 2015-04-07 ES ES15717051T patent/ES2958492T3/es active Active
- 2015-04-07 PL PL15717051.5T patent/PL3129057T3/pl unknown
- 2015-04-07 CA CA3209430A patent/CA3209430A1/en active Pending
- 2015-04-07 EP EP23182534.0A patent/EP4285998A3/en active Pending
- 2015-04-07 DK DK15717051.5T patent/DK3129057T3/da active
- 2015-04-07 MX MX2016013039A patent/MX392452B/es unknown
- 2015-04-07 CA CA2980885A patent/CA2980885C/en active Active
-
2016
- 2016-10-04 MX MX2022006003A patent/MX2022006003A/es unknown
-
2019
- 2019-07-25 US US16/522,216 patent/US11248016B2/en active Active
-
2020
- 2020-04-02 AU AU2020202332A patent/AU2020202332B9/en active Active
-
2022
- 2022-06-01 AU AU2022203774A patent/AU2022203774A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| MX392452B (es) | 2025-03-24 |
| AU2020202332B9 (en) | 2022-04-07 |
| MX2016013039A (es) | 2017-04-27 |
| CN106413753B (zh) | 2022-04-12 |
| MX2022006003A (es) | 2022-06-22 |
| EP4285998A3 (en) | 2024-02-14 |
| AU2022203774A1 (en) | 2022-06-23 |
| AU2015242363A1 (en) | 2016-11-03 |
| EP3129057A1 (en) | 2017-02-15 |
| CN114685414A (zh) | 2022-07-01 |
| EP4285998A2 (en) | 2023-12-06 |
| CA2980885C (en) | 2023-10-03 |
| CA3209430A1 (en) | 2015-10-08 |
| WO2015150839A1 (en) | 2015-10-08 |
| DK3129057T3 (da) | 2023-10-02 |
| GB201406172D0 (en) | 2014-05-21 |
| US10428102B2 (en) | 2019-10-01 |
| US20170275323A1 (en) | 2017-09-28 |
| US11248016B2 (en) | 2022-02-15 |
| AU2015242363C1 (en) | 2022-09-22 |
| CN106413753A (zh) | 2017-02-15 |
| EP3129057B1 (en) | 2023-07-05 |
| AU2020202332A1 (en) | 2020-04-23 |
| CA2980885A1 (en) | 2015-10-08 |
| AU2020202332B2 (en) | 2022-03-17 |
| ES2958492T3 (es) | 2024-02-09 |
| US20190382433A1 (en) | 2019-12-19 |
| AU2015242363B2 (en) | 2020-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252532A0 (en) | Polycyclic carbamoylpyridone compounds and their pharmaceutical use | |
| IL254552A0 (en) | Polycyclic carbamoylpyridone compounds and their pharmaceutical uses | |
| PL3515420T3 (pl) | Kompozycje farmaceutyczne do zastosowania w terapii zapalenia brzegów powiek | |
| GB201511382D0 (en) | Novel compounds and their use in therapy | |
| IL252967A0 (en) | Pharmaceutical preparations containing plasminogen and their uses | |
| IL265970B (en) | Sulfoxyalkyl organonitro compounds and related compounds and pharmaceutical preparations for use in medicine | |
| IL251120A0 (en) | Immunogenic/therapeutic glycoside preparations and their uses | |
| ZA201703398B (en) | Pharmaceutical composition and methods | |
| PL3129057T3 (pl) | Glikolipidy i ich kompozycje farmaceutyczne do stosowania w leczeniu | |
| LT3057589T (lt) | (s)-pirlindolas ir jo farmaciniu požiūriu priimtinos druskos, skirti naudoti medicinoje | |
| SMT202200151T1 (it) | Composizioni e metodi per l’uso nel trattamento di omocistinuria. | |
| IL248854A0 (en) | R-pyralindole and its pharmaceutically acceptable salts for use in medicine | |
| SG10202106375UA (en) | Pharmaceutical compositions and use thereof | |
| IL249440B (en) | Pharmaceutical compounds and preparations containing them for the treatment of neurodegenerative diseases | |
| GB201519644D0 (en) | Therapy and pharmaceutical composition | |
| GB201409978D0 (en) | Novel compounds and their use in therapy | |
| GB201404391D0 (en) | Novel compositions having use in therapy | |
| GB201419559D0 (en) | Therapeutic compositions and methods | |
| GB201502816D0 (en) | Novel Compositions having use in therapy |